This trial is testing the effects of dexamethasone on lung cancer patients who have not responded to previous treatment. Imaging tests will be used to see if dexamethasone affects how tumors grow and respond to treatments.
- Non-small Cell Lung Cancer Stage IIIB
- Non-Small Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
1 Primary · 4 Secondary · Reporting Duration: Day 6-9
Side Effects for
1 Treatment Group
Treatment (dexamethasone, 18F-FLT PET)
1 of 1
10 Total Participants · 1 Treatment Group
Primary Treatment: Dexamethasone · No Placebo Group · N/A
Who is running the clinical trial?
Age Any Age · All Participants · 11 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are authorized to join the trial?
"That is correct. Clinicaltrials.gov attests that this research project, which was originally posted in June 2016, still seeks participants. 10 people are needed to enrol at the single trial site for inclusion into the study." - Anonymous Online Contributor
Are there any available slots for this research study?
"Affirmative. Clinicaltrials.gov attests that this medical trial, which was published on June 1st 2016, is actively recruiting patients. The team aims to enroll 10 individuals across a single site." - Anonymous Online Contributor
Do other studies exist that delve into the use of Dexamethasone?
"Currently, there are 555 studies in progress concerning Dexamethasone with 143 of them being Phase 3 trials. There is a concentration of research based around Elk Grove Village, Illinois; however the drug's clinical testing spans across 18,660 different sites worldwide." - Anonymous Online Contributor
What conditions typically warrant Dexamethasone usage?
"Dexamethasone is typically administered for ophthalmic and sympathic purposes. It can also be utilized to address cases of branch retinal vein occlusion, macular edema, and other eye-related issues." - Anonymous Online Contributor